Navigation Links
In Letter to Congress, NORD Urges Action on Healthcare Reform
Date:7/31/2009

DANBURY, Conn., July 31 /PRNewswire-USNewswire/ -- The following letter regarding health care reform was sent to all members of Congress today by the National Organization for Rare Disorders (NORD):

July 31, 2009

Dear Member of Congress:

On behalf of the 30 million Americans who are affected by one of the nearly 7,000 rare disorders, we urge you to pass comprehensive health reform legislation designed to assure that every American, regardless of health status, has access to affordable, meaningful health insurance coverage. Failure to pass such long-overdue legislation this year would be devastating and an unacceptable option for people with rare diseases and their families, as well as the millions of other Americans who similarly are burdened by chronic illness.

Today, far too many people under the age of 65 with serious medical conditions have inadequate or no access to health insurance. In most areas of the country, in the absence of employer-based coverage, medical underwriting practices by insurers can, and too often do, result in pre-existing condition limits on coverage, higher health insurance premiums and, for many, outright denials of coverage. People with rare diseases customarily incur substantial medical expenses, first in efforts to obtain an accurate diagnosis, and thereafter from hospitalizations, physicians' office visits, and -- for those fortunate enough to have a therapeutic drug, biological, device or medical food -- from costs of these treatments, some of which amount to tens of thousands of dollars per year.

As such, for people with rare diseases -- and indeed for all Americans -- three basic principles should be part of any acceptable reform. First, health reform must prohibit insurance companies from denying or limiting coverage, or charging patients more for premiums based on health status. Second, patients must be protected against catastrophic out-of-pocket costs and annual or lifetime insurance caps. Third, health reform must include tax credits and other direct financing support sufficient to assure that lower and middle income patients can afford coverage.

We recognize and accept that with these critically important health care benefits comes an individual responsibility to purchase health insurance. Moreover, NORD will be a constructive force in supporting measures that provide for necessary savings and revenues to ensure that these benefits are paid for and managed in a fiscally prudent fashion.

We are pleased that many Congressional leaders are pursuing policies that achieve NORD's principles. While comprehensive federal health reform cannot be all things to all people, it must not be an empty promise to Americans, including those who currently suffer from, and those who will develop, rare diseases.

Finally, we understand and accept that compromises will be made as health reform legislation makes its way through the legislative process. While the basic patient protections outlined above are fundamental to any reform, we recognize that there will be design approaches that would not be our first choice. However, we pledge that we will not allow the perfect to be the enemy of the good. To be clear, though, we also strongly believe that failure to act is an explicit policy choice to preserve the unacceptable status quo. Such a choice has dire access and cost consequences that are intolerable for individuals, families, and the country.

We thank you for your commitment to meaningful health reform. We are eager to work with you to assure passage of legislation that makes health insurance affordable and accessible for every American, regardless of health status.

Sincerely,

Peter L. Saltonstall

President and CEO

National Organization for Rare Disorders (NORD)


'/>"/>
SOURCE National Organization for Rare Disorders (NORD)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insurance Companies
2. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
3. FertilityAuthority Introduces E-Newsletter, The Daily Shot
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. New Letter to Rangel, Waxman, Miller from National Seniors Coalition Outlines Concerns With House Tri-Committee Health Reform Bill
6. Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus
7. June 2009 Mayo Clinic Health Letter Highlights Probiotics, Carotid Artery and Breast Cancer Treatments
8. Connectyx Technologies Holdings Group, Inc. Signs an Agreement with Healthy Directions, LLC, Americas Largest Publisher of Alternative and Complementary Health Newsletters to Distribute its MedFlash EPHR
9. KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
10. Matrixx Initiatives, Inc. Received a Warning Letter From the Food and Drug Administration
11. Endologix Receives Nasdaq Letter on Director Independence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... ... excited to announce the next generation for LASIK in Manhattan with Contoura Vision, ... most technologically advanced laser systems available in the United States to correct nearsightedness ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... Community”: a gripping look at the religious stand in the sensitive matter ... love and compassion. “The Ministry of Reconciliation: A Compassionate and Realistic Approach to ...
(Date:9/25/2017)... ... ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the New ... with the new NEXTY Gold Award at the Natural Products Expo East trade show ... is reserved for just those companies that hit high marks on the criteria of ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... September 28, 2017 to deliver a powerful message of teamwork, unity and collaboration ... Feature film writer/director Robert Adetuyi (Beat the World, Stomp the Yard) and Grammy-nominated ...
(Date:9/24/2017)... Michigan (PRWEB) , ... September 23, 2017 , ... Throughout ... do no harm. , Every day, physicians, nurses and other providers work to ... treatments and innovative industry processes. , But U.S. Senators today are threatening to ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
Breaking Medicine Technology: